AAAAAA

   
Results: 1-9 |
Results: 9
The psychoactive ingredient of marijuana induces behavioural sensitization
Authors: Rubino, T Vigano, D Massi, P Parolaro, D
Citation: T. Rubino et al., The psychoactive ingredient of marijuana induces behavioural sensitization, EUR J NEURO, 14(5), 2001, pp. 884-886
A longitudinal study of velogenic Newcastle disease virus genotypes isolated in Italy between 1960 and 2000
Authors: Herczeg, J Pascucci, S Massi, P Luini, M Selli, L Capua, I Lomniczi, B
Citation: J. Herczeg et al., A longitudinal study of velogenic Newcastle disease virus genotypes isolated in Italy between 1960 and 2000, AVIAN PATH, 30(2), 2001, pp. 163-168
Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects
Authors: Massi, P Vaccani, A Romorini, S Parolaro, D
Citation: P. Massi et al., Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects, J NEUROIMM, 117(1-2), 2001, pp. 116-124
In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors
Authors: Sacerdote, P Massi, P Panerai, AE Parolaro, D
Citation: P. Sacerdote et al., In vivo and in vitro treatment with the synthetic cannabinoid CP55,940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors, J NEUROIMM, 109(2), 2000, pp. 155-163
Chronic Delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions
Authors: Rubino, T Vigano, D Massi, P Spinello, M Zagato, E Giagnoni, G Parolaro, D
Citation: T. Rubino et al., Chronic Delta-9-tetrahydrocannabinol treatment increases cAMP levels and cAMP-dependent protein kinase activity in some rat brain regions, NEUROPHARM, 39(7), 2000, pp. 1331-1336
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome
Authors: Rubino, T Massi, P Vigano, D Fuzio, D Parolaro, D
Citation: T. Rubino et al., Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome, LIFE SCI, 66(22), 2000, pp. 2213-2219
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the syntheticcannabinoid compound CP55,940
Authors: Rubino, T Vigano, D Massi, P Parolaro, D
Citation: T. Rubino et al., Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the syntheticcannabinoid compound CP55,940, J NEUROCHEM, 75(5), 2000, pp. 2080-2086
Relative involvement of cannabinoid CB1 and CB2 receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activity
Authors: Massi, P Fuzio, D Vigano, D Sacerdote, P Parolaro, D
Citation: P. Massi et al., Relative involvement of cannabinoid CB1 and CB2 receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activity, EUR J PHARM, 387(3), 2000, pp. 343-347
Immune function alterations in mice tolerant to Delta(9)-tetrahydrocannabinol: functional and biochemical parameters
Authors: Massi, P Sacerdote, P Ponti, W Fuzio, D Manfredi, B Vigano, D Rubino, T Bardotti, M Parolaro, D
Citation: P. Massi et al., Immune function alterations in mice tolerant to Delta(9)-tetrahydrocannabinol: functional and biochemical parameters, J NEUROIMM, 92(1-2), 1998, pp. 60-66
Risultati: 1-9 |